Incidence of grade 3 and 4 blood count and liver test adverse events within the first 10 days after initiating HCQ therapy in hospitalized patients with COVID-19.
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://figshare.com/articles/dataset/Incidence_of_grade_3_and_4_blood_count_and_liver_test_adverse_events_within_the_first_10_days_after_initiating_HCQ_therapy_in_hospitalized_patients_with_COVID-19_/12701292
下载链接
链接失效反馈官方服务：
资源简介：
Incidence of grade 3 and 4 blood count and liver test adverse events within the first 10 days after initiating HCQ therapy in hospitalized patients with COVID-19.
创建时间：
2020-07-23
